PRTN3 and rheumatoid arthritis: Out of these nine sera, five sera (9.8%) were not identified by the fibrin/filaggrin chimeric peptide, indicating the additional diagnostic value in ACPA-negative RA by combining analysis of chimeric enolase peptides.